openPR Logo
Press release

Human Immunodeficiency Virus (HIV) Diagnosis Global Market Report 2024 by The Business Research Company | Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Roche Diagnostics , Becton Dickinson and Company, Hologic Inc., bioMérieux

Human Immunodeficiency Virus (HIV) Diagnosis Market Trends And Strategies

Human Immunodeficiency Virus (HIV) Diagnosis Market Trends And Strategies

The HIV diagnosis market size has grown rapidly in recent years. It will grow from $3.79 billion in 2023 to $4.2 billion in 2024 at a compound annual growth rate (CAGR) of 11%. The growth in the historic period can be attributed to expansion of voluntary counseling and testing, development of HIV antibody tests, emergence of the HIV/AIDS epidemic, and community-led and peer-led initiatives.

The HIV diagnosis market size is expected to see rapid growth in the next few years. It will grow to $6.42 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to public health campaigns and awareness initiatives, focus on equity and inclusivity, routine testing in healthcare settings, community-led and peer-led approaches, and expansion of self-testing. Major trends in the forecast period include advancements in testing technologies, focus on targeted testing strategies, community-based testing and outreach, emphasis on equity and inclusivity, and policy and funding priorities.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=15587&type=smp

Human Immunodeficiency Virus (HIV) Diagnosis Market Major Segments
The human immunodeficiency virus (HIV) diagnosis market covered in this report is segmented -

1) By Product: Consumables, Instruments, Software And Services
2) By Mode: Self-Test, Lab-Based
3) By End User: Diagnostic Laboratories, Hospitals, Research Institutions

Key Driver - Physical Inactivity Among Menopausal Women Driving Growth In The Menopause Market

The rising blood donation is expected to propel the growth of the HIV diagnosis market going forward. Blood donation refers to the voluntary act of giving blood through phlebotomy, where a needle is inserted into a vein to collect blood. The rise in blood donation combines advancements in medical technology, community engagement, and improved donor recruitment and retention strategies. With more people donating blood, a larger pool of samples is available for HIV testing. This increased availability of blood samples allows for more comprehensive screening for HIV antibodies or antigens, improving the accuracy and reliability of HIV diagnosis. For instance, NHS Blood and Transplant, a UK-based government agency, increased the number of new blood donors from 119,016 in 2022-2023 to 119,371 in 2023-2024. Therefore, rising blood donation is driving the growth of the HIV diagnosis market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=15587&type=smp

Prominent Trend - Advancing Chip-Based Real-Time PCR For HIV Detection

Major companies operating in the HIV diagnosis market are developing chip-based real-time PCR test solutions for HIV to improve accuracy, reduce turnaround time, and enhance accessibility. Chip-based real-time PCR test solutions for HIV are diagnostic tools that utilize microfluidic chips or small integrated circuits to conduct real-time polymerase chain reaction (PCR) tests for detecting HIV. For instance, in August 2022, Molbio Diagnostics, an India-based molecular diagnostics manufacturer, launched the Truenat HIV-1 test, a chip-based real-time PCR test for the quantitative detection and diagnosis of human immunodeficiency virus type 1 (HIV-1) in whole blood and plasma. This test is designed to aid in the monitoring of the HIV-1 viral load in patients with HIV-1 infection. The test is based on Taqman chemistry and features high primer sensitivity and specificity. It requires a minimal sample volume of 6 mcL and includes an intelligent chip with lot-specific data to quantify results. The test consists of a chip re-use lock and a reaction port with contamination- and evaporation-resistant design.

Human Immunodeficiency Virus (HIV) Diagnosis Market Players
Major companies operating in the human immunodeficiency virus (HIV) diagnosis market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Roche Diagnostics , Becton Dickinson and Company, Hologic Inc., bioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corporation, Alere Inc., Cepheid Inc. , OraSure Technologies Inc., Advanced Instruments Inc., BBI Solutions, Chembio Diagnostic Systems Inc., BioLytical Laboratories Inc., Avioq Inc., Advanced Biochemicals Ltd., Advanced Molecular Diagnostics, Atila BioSystems Inc., BioAssay Works LLC, Chemtron Biotech Inc.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/human-immunodeficiency-virus-hiv-diagnosis-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the HIV diagnosis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human immunodeficiency virus (HIV) diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Human Immunodeficiency Virus (HIV) Diagnosis Market Report Structure
3. Human Immunodeficiency Virus (HIV) Diagnosis Market Trends And Strategies
4. Human Immunodeficiency Virus (HIV) Diagnosis Market - Macro Economic Scenario
5. Human Immunodeficiency Virus (HIV) Diagnosis Market Size And Growth
…..
27. Human Immunodeficiency Virus (HIV) Diagnosis Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Human Immunodeficiency Virus (HIV) Diagnosis Global Market Report 2024 by The Business Research Company | Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Roche Diagnostics , Becton Dickinson and Company, Hologic Inc., bioMérieux here

News-ID: 3554174 • Views:

More Releases from the business research company

Rising Demand For Loans Fuels Growth In The Asset-Based Lending Market: Powering Innovation and Expansion in the Asset-Based Lending Market by 2025
Rising Demand For Loans Fuels Growth In The Asset-Based Lending Market: Powering …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Asset-Based Lending Market Through 2025? In recent times, there's been a significant expansion in the size of the asset-based lending market. This increase will continue from $785.6 billion in 2024 to $891.89 billion in 2025, with a compound annual growth rate (CAGR)
Future of the Usage-Based Insurance Market: Trends, Innovations, and Key Forecasts Through 2034
Future of the Usage-Based Insurance Market: Trends, Innovations, and Key Forecas …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Usage-Based Insurance Market Size Growth Forecast: What to Expect by 2025? The market for usage-based insurance has seen a meteoric rise in size in the past few years. It is projected to expand from a valuation of $63.07 billion in 2024 to an impressive $82.7 billion in 2025, representing
Global Reinsurance Market Projected to Grow at 10.2% CAGR, Reaching $1016.51 Billion by 2029
Global Reinsurance Market Projected to Grow at 10.2% CAGR, Reaching $1016.51 Bil …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Reinsurance Industry Market Size Be by 2025? The dimension of the reinsurance market has been escalating significantly in the past few years. It is estimated to balloon from $631.56 billion in 2024 to a whopping $689.74 billion in 2025, projecting a compound annual growth rate (CAGR)
Comprehensive Online Trading Platform Market Forecast 2025-2034: Growth Trends and Strategic Shifts
Comprehensive Online Trading Platform Market Forecast 2025-2034: Growth Trends a …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Online Trading Platform Market Size Valuation Forecast: What Will the Market Be Worth by 2025? There has been consistent growth in the size of the online trading platform market over the past few years. It is expected to escalate from $11.42 billion in 2024 to $11.97 billion in 2025,

All 5 Releases


More Releases for HIV

HIV Drugs Market - Defeating HIV Together: Advancing Treatment Options for a Bri …
Newark, New Castle, USA: The "HIV Drugs Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors HIV Drugs Market: https://www.growthplusreports.com/report/hiv-drugs-market/7792 This latest report researches the industry structure, sales, revenue,
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways